Experimental application of target-specific immunoconjugates containing daunomycin as the cytocidal component.
Diener
E
E
University of Alberta, Edmonton, Canada.
Xie
S S
SS
Yu
L Z
LZ
Longenecker
B M
BM
Sinha
A A
AA
D000818:Animals; D000906:Antibodies / Q000008:administration & dosage; D001402:B-Lymphocytes / Q000187:drug effects / Q000276:immunology; D016026:Bone Marrow Transplantation / Q000502:physiology; D002470:Cell Survival / Q000187:drug effects; D004261:DNA Replication / Q000187:drug effects; D003630:Daunorubicin / Q000008:administration & dosage / Q000494:pharmacology* / Q000627:therapeutic use; D006410:Hematopoiesis / Q000187:drug effects; D006801:Humans; D000922:Immunotoxins / Q000627:therapeutic use*; D014407:Tumor Cells, Cultured
D000906:Antibodies; D000922:Immunotoxins; D003630:Daunorubicin